NFκB: Cell survival or cell death?

Signal Transduction

Volumn 5, Issue 6, 2005, Pages 334-349

  Strozyk, Elwira ^a   Kulms, Dagmar ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Apoptosis; Cancer; NF B; p53

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR REL;

APOPTOSIS; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 30044439839     PISSN: 16154053     EISSN: None     Source Type: Journal    
DOI: 10.1002/sita.200500070     Document Type: Review

References (152)

1. Baeuerle, P. A., Baltimore, D. (1996) NFκB: Ten Years After. Cell 87: 13-20.
2. Bonizzi, G., Karin, M. (2004) The two NFκB activation pathways and their role in innate and adoptive immunity. Trends Immunol. 25: 280-288.
3. Gosh, S., Karin, M. (2002) Missing Pieces in the NFκB Puzzle. Cell 109: 81-96.
4. Banno, T., Gazel, A., Blumenberg, M. (2005) Pathway specific profiling identifies the NFκB-dependent tumor necrosis factor a-regulated genes in epidermal keratinocytes. J. Biol. Chem. 280: 18973-18980.
5. Muller, M., Morotti, A., Ponzetto, C. (2002) Activation of NFκB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol. Cell. Biol. 22: 1060-1072.
6. Govind, S. (1999) Control of development and immunity by Rel transcription factors in Drosophila. Oncogene 18: 6875-6887.
7. König, H.G., Kögel, D., Rami, A., Prehn, J.H.M. (2005) TGF-β 1 activates two distinct type I receptors in neurons: implications for neuronal NFκB signalling. J. Cell Biol. 168: 1077-1086.
8. Verma, I.M., Stevenson, J. (1997) IκB kinase: Beginning, not the end. Proc. Natl. Acad. Sci. U.S.A. 94: 11758-11760.
9. Jono, H., Lim, J. H., L. F., Chen, Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., Li, J. D. (2004): NFκB Is Essential for Induction of CYLD, the Negative Regulator of NFκB, J. Biol. Chem. 279: 36171-36174.
10. Aggarwal, B. B. (2004) Nuclear Factor-kB: The enemy within. Cancer Cell 6: 203-208.
11. Laque, I., Gelinas, C. (1997) Rel/NFκB and IκB factors in oncogenesis. Semin. Cancer Biol. 8: 103-11.
12. Grilli, M., Memo, M. (1999) NFκB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57: 1-7.
13. Foxwell, B., Browne, K., Bondeson, J., Clarke, C., Martin, R., Brennan, F., Feldmann, M. (1998) Efficient adenoviral infection with IκB reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NFκB dependent. Proc. Natl. Acad. Sci. U.S.A. 95: 8211-8215.
14. Barnes, P. J., Adcock, I. M. (1998) Transcription factors and asthma. Eur. Resp. J. 12: 221-234.
15. Wang, C. Y., Cusack, J. C., Jr., Liu, R., Baldwin, A. S. Jr. (1999) Control of inducible chemoresistance. Enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB. Nat. Med. 5: 412-417.
16. Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., Verma, I. (2002) P53 stabilisation is decreased upon NKkB activation: A role for NKkB in aquisition of resistance to chemotherapy. Cancer Cell 1: 493-503.
17. Perkins, N. D. (2004) NFκB tumor promoter or suppressor? Trends Immunol. 14: 64-69.
18. Thanos, D., Maniatis, T. (1995) NFκB: a lesson in family values. Cell 80: 529-532.
19. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., Miyamoto, S. (1995) Rel/NFκB/IκB family: intimate tales of association and dissociation. Genes Dev. 9: 2723-2735.
20. Fujita, T., Nolan, G. P., Ghosh, S., Baltimore. D. (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NFkappa B. Genes Dev. 6: 775-787.
21. Baeuerle, P. A., Baltimore, D. (1988) IκB: a specific inhibitor of the NFkappa B transcription factor. Science 242: 540-546.
22. Dobrzanski, P., Ryseck, R. P., Bravo, R (1995) Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10: 1003-1007.
23. Palombella, V. J., Rando, O. J., Goldberg, A. L, Maniatis, T. (1994) The ubiquitin-proteasome pathway is required for processing the NFκB1 precursor protein and the activation of NFκB. Cell 78: 773-785.
24. Betts, J. C., Nabel, G. J. (1996) Differential regulation of NFκB2 (p100) processing and control by amino-terminal sequences. Mol. Cell. Biol. 16: 6363-6371.
25. Cogswell, P. C., Scheinman, R. I., Baldwin, A. S., Jr. (1993) Promoter of the Human NF-κB p50/p105 Gene. Regulation of NF-κB subunits and by C-REL. J. Immunol. 150: 2794-2804.
26. Ten, R. M., Payal, C. V., Israel, N., Le Bail, O., Mattei, M.-G., Virelizierl, J. L., Kourilsky, P., Israel, A. (1992) The characterization of the promoter of the gene encoding the p50 subunit of NFκB indicates that it participates in its own regulation. EMBO J. 1: 195-203.
27. Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F.G., Scheidreit, C., Leutz, A. (1999) The Bcl-3 oncoprotein acts as a bridging factor between NFκB/Rel and nuclear co-regulators. Oncogene 18: 3316-23.
28. Johnson, C., Van Antwerp, D., Hope, D. J. (1999) An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J. 18: 6682-6693.
29. Claudio, E., Brown, K., Park, S., Wang, H., Siebenlist, U. (2002) BAFF-induced NEMO-independent processing of NFκB2 in maturing B cells. Nat. Immunol. 3: 958-965.
30. Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z. W., Karin, M., Ware, C. F., Green, D. R. (2002) The lympho-toxin-b receptor induces different patterns of gene expression via two NFκB pathways. Immunity 17: 525-535.
31. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., Siebenlist, U. (1995) Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
32. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., Karin, M. (1997) A cytokine responsive IκB kinase that activates the transcription factor NFκB. Nature 388: 548-554.
33. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T, Farmer, H., Ashworth, A., Mosialos, G. (2003) CYLD is a deubiquitinating enzyme that negatively regulates activation of the transcription factor NFkappaB by specific tumor-necrosis factor receptors (TNFRs). Nature 424: 793-796.
34. Wertz, I.E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., Ma, A., Koonin, E. V., Dixit, V. M., (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB-signalling. Nature 430: 694-699.
35. Evans, P. C., Ovaa, H., Hamon, M., Kilshaw, P. J., Hamm, S., Bauer, S., Ploegh, H. L., Smith, T. S. (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-uiquitin activity. Biochem. J. 378: 72-734.
36. Liu, W.K., Yen, P. F., Chia-Yi Chien, C. Y., Fann, M. J., Su, J. Y., Chou, C. K. (2004) The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKγ to block activation of the transcription factor NFκB and potentiate apoptosis. Biochem. J. 378: 867-876.
37. Heyninck, K., Marja, M., Kreike, M. M., Beyaert, R. (2003) Structure-function analysis of the A20-binding inhibitor of NFκB activation, ABIN-1. FEBS Lett. 536: 135-140.
38. Lee, E.G., Boone, D.L., Chai, S., Libby, S.L., Chien, M., Lodolce, J.P., Ma, A. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354.
39. Rudolph, D., Yeh W.C., Wakeham A., Rudolph B., D. Nallainathan D., Potter J., Elia A. J., Mak, T.W. (2000) Severe liver degeneration and lack of NFκB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14: 854-862.
40. Alcamo, E., Mizgerd, J. P., Horwitz, B. H., Bronson, R., Beg, A. A., Scott, M., Doerschuk, C. M., Hynes, R. O., Baltimore, D. (2001) Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NFκB in leukocyte recruitment. J. Immunol. 167: 1592-1600.
41. Li, Q., Van Antwerp, D., Mercurio, P., Lee, K. P., Verma, I. M., (1999) Severe liver degradation in mice lacking the κB kinase 2. Science 284: 321-325.
42. Grigoriadis, G., Zhan, Y., Grumont, R.J., Metcalf, D., Handman, E., Cheers, C., Gerondakis, S. (1996) The Rel subunit of NFκB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 15: 7099-7107.
43. Karin, M., Yamamoto, Y., Wang, Q. M. (2004) The IKK NFκB system: A treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26.
44. Novack, D. V., Yin, L., Hagen-Stapelton, A., Schreiber, R. D., Goeddel, D. V., Ross, F. P., Teitelbaum, S. L. (2003) The IκB function of NFκB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198: 771-781.
45. Ghosh, S., May, M. J., Kopp, E. B. (1998) NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 255-260.
46. Leung, T. H., Hoffmann, A., Baltimore, D. (2004) One nucleotide in a κB site can determine cofactor specificity for NFκB dimers. Cell 118: 453-464.
47. Saccani, S., Pantano, S., Natoli, G. (2001) Two waves of nuclear factor kB recruitment to target promoters. J. Exp. Med. 193: 1351-1359.
48. Knoepfer, P. S., Eisenman, R. N. (1999) Sin meets NuRD and other tails of repression. Cell 99: 447-450.
49. Ashburner, B. P., Westerheide, S. D., Baldwin, A. S. Jr. (2001) The p65 (RelA) subunit of NFκB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:7065-7077.
50. Yamamoto, Y., Verma, U. N., Prajapati , S., Kwak, Y. T., Gaynor, R. B. (2003) Histone H3 phosphorylation by IKKα is critical for cytokine-induced gene expression. Nature 423: 655-659.
51. Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., Baldwin, A. S. (2003) A nucleosomal function for IκB kinase-a in NFκB-dependent gene expression. Nature 423: 659-663.
52. Saccani, S., Pantano, S., Natoli G. (2002) p38-dependent marking of inflammatory genes for increased NFκB recruitment. Nat. Immunol. 3: 69-75.
53. Zhong, H., May, M. J., Jimi, E., Ghosh, S. (2002) The phosphorylation status of nuclear NFκB determines its association with CBP/p300 or HDAC-1. Mol. Cell. 9: 625-636.
54. Sizemore, N., Leung, S., Stark, G. R. (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NFκB p65/RelA subunit. Mol. Cell. Biol. 19: 4798-4805.
55. Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., Stark, G. R. (2002) Distinct roles of the IκB kinase a and b subunits in liberating nuclear factor κB (NFκB) from IκB and in phosphorylating the p65 subunit of NFκB. J. Biol. Chem. 277: 3863-3869.
56. Chen, L. P., Mu, Y., Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NFκB. EMBO J. 21, 6539-6548.
57. Kiernan, R., Bres, V., Ng, R. W., Coudait, M. P., El Messaoudi, S., Sardet, C., Jin, D. Y., Emiliani, S., Benkirane, M. (2003) Post-activation turn-off of NFκB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278: 2758-2766.
58. Saccani, S., Pantano, S., Natoli, G. (2003) Modulation of NFκB activity by exchange of dimers. Mol. Cell 11: 1563-1574.
59. Zaidi, G., Supakar, P. C. (2003) Identification of a nuclear protein interacting with a novel site on rat androgen receptor promoter after transcription factor NFκB is displaced from adjacent site. Mol. Biol. Rep. 30: 121-125.
60. Nunez, G., Benedict, M.A., Hu, Y., Inohara, N. (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245.
61. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, P., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., Peter, M. E. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687.
62. Wang X. (2001) The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933
63. Micheau, O., Tschopp, J. (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-90.
64. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
65. Tschopp, J., Irmler, M., Thome, M. (1998) Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10: 552-558.
66. Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., Grutter, M. G. (2002) The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277: 45162-45171.
67. Kataoka, T., Tschopp, J. (2004) N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kB signaling pathway. Mol. Cell. Biol. 24: 2627-2636.
68. Dohrman, A., Kataoka, T, Cuenin, S., Russell, J. Q., Tschopp, J., Budd, R.C. (2005) Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation. J. Immunol. 174: 5270-5278.
69. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., Baldwin, A. S., Jr (1998) NFkappaB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase 8 activation. Science 281: 1680-1683.
70. La Casse, E. C., Baird, S., Korneluk, R. G., MacKenzie, A. E.(1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247-59.
71. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., Tschopp, J. (2001) NFκB Signals Induce the Expression of C-FLIP. Mol. Cell. Biol. 21: 5299-5305.
72. Zong, W. X., Edelstein, L. C., Chen, C., Bash, J., Gelinas C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NFkappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13: 382-387.
73. Cao, Y., Karin, M. (2003) NFkappaB in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia8: 215-223.
74. Li, Q., Withoff, S., Verma, I. M. (2005) Inflammation-associated cancer: NFκB is the lynchpin. Trends Immunol. 26: 318-325.
75. Maeda, S., Chang, L., Li, Z. W., Luo, J. L., Leffert, H., Karin, M. (2003) IKKβeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 19: 725-737.
76. Chen L.-W., Egan, L., Li, Z.-W., Greten, F. R., Kagnoff, M. F., Karin, M. (2003) The two faces of IKK and NFκB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9: 575-581.
77. Tissing, W. J. E., Meijerink, J. P. P., den Boer, M. L., Pieters R. (2003) Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 17: 17-25.
78. Perkins, N. D. (2004) Regulation of NFκB by atypical activators and tumor suppressors, Biochem. Soc. Trans. 32: 936-939.
79. Ryan, K. M., Ernst, M., Rice, N. R., Vousden, K. H. (2000) Role of NFκB in p-53-mediated programmed cell death. Nature 404: 892-897.
80. Stadler, R. (2002) Treatment of cutaneous T cell lymphoma. Skin Pharmacol. Appl. Skin Physiol. 15:139-146.
81. Nistico, S., Costanzo, A.R., Saraceno, R., Chimenti, S. (2004) Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br. J. Dermatol. 151: 877-879.
82. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., Goodwin, R. G. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
83. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C., and Lynch, D. H. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157-163.
84. Kothny-Wilkes, G., Kulms, D., Pöppelmann, B., Luger, T. A., Kubin, M., Schwarz, T. (1998) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 273: 29247-29253.
85. Pöppelmann, B., Klimmek, K., Strozyk, E., Voss, R., Schwarz, T., Kulms, D. (2005) NFκB-dependent down-regulation of TRAF proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis. J. Biol. Chem. 280: 15635-16643.
86. Chen, G., Goeddel, D. V. (2002) TNFR1 Signaling: A Beautiful Pathway. Science 296: 1634-1635.
87. Deveraux, Q. L., Roy, N., Stennicke, H. R., Van Arsdale, T., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesan, G. S., Reed, J. C. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17: 2215-2223.
88. Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T., Thompson, C. B. (2001) Characterisation of XIAP-deficient mice. Mol. Cell. Biol. 21: 3604-3608.
89. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K. Steiner, V., Bodmer, J. L., Schröter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
90. Karin, M., Lin, A. (2002) NFκB at the crossroads of life and death. Nat. Imunol. 3: 221-227.
91. L protein by caspase-3-like proteases. Oncogene 17: 1295-1304.
92. Nakagawa, T., Yuan, J. (2000) Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J. Cell. Biol. 150: 887-894.
93. Baldwin, A. S. (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NFκB. J. Clin. Invest. 107: 241-246.
94. Wang, C. Y., Guttridge, D. C., Mayo, M. W., Baldwin, A. S. Jr. (1999) NFκB induces expression of the Bcl-2 homologue to preferentially suppress chemotherapy -induced apoptosis. Mol. Cell. Biol. 19: 5923-5929.
95. Chen, C., Edelstein, L. C., Gelinas, C. T. (2000) The Rel/NFκB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20: 2687-2695.
96. Wu, H., Lozano, G. (1994) NFκB Activation of p53. J. Chem. Biol. 269: 20067-20074.
97. Pahl, H. L. (1999) Activators and target genes of Rel/NFκB transcription factors. Oncogene 18: 6853-6866.
98. Poole, J. C., Thain, A., Perkins, N. D., Robinson, I. B. (2004) Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect on non-steroidal anti-inflammatory drugs. Cell Cycle 3: 931-940.
99. Lowe, S. W., Ruley, H. E., Jacks, T., Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer drugs. Cell 74: 957-967.
100. Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H., Miyamoto, S. (2003) Sequential modification of ÉÅÈË/ ÉÊÊã by SUMO-1 and ubiquitin mediates NFκB activation by genotoxic stress. Cell 115: 565-576.
101. Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., Verma, I. M. (2003) IκB kinase-independent IκBα degradation pathway: Functional NFκB activity and implications for cancer therapy. Mol. Cell, Biol. 23: 8070-8083.
102. rsk signaling pathway in response to distinct forms of DNA damage. Mol. Cell. Biol. 24: 1823-1835.
103. Hur, G. M., Lewis, J., Yang, Q., Lin, Y., Nakano, H., Nedospasov, S., Liu, Z. G. (2003) The death domain kinase RIP has an essential role in DNA damage-induced NFκB activation. Genes Dev. 17: 873-882.
104. Culmsee, C., Siewe, J., Junker, V., Retiounskaia, M., Schwarz, S., Camandola, S., El-Metainy, S., Behnke, H., Mattson, M. P., Krieglstein, J. (2003) Reciprocal inhibition of p53 and nuclear factor-kB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23: 8586-8595.
105. Aleyasin, H., Cregan, S. P., Iyirhiaro, G., O'Hare, M. J., Callaghan, S. M., Slack, R. S., Park, D. S. (2004) Nuclear factor-κB modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. 24: 2963-2973.
106. Bohuslav, J., Chen, L. P., Kwon, H., Mu, Y., Greene, W.C. (2004) p53 induces NFκB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol. Chem. 279: 26115-26125.
107. Masdehors, P., Omura, S., Merle-Beral, H., Mentz, P., Cosset, J. M., Dumont, J., Magdelenat, H., Delic, J. (1999) Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin. Br. J. Haematol. 105: 752-757.
108. Voorhees, P. M., Dees, E. C., O'Neil, B., Orlowski, R. Z. (2003) The protesome as a target for cancer therapy. Clin. Cancer Res. 9: 6316-6325.
109. Wang, C. Y., Mayo, M. W., Baldwin Jr., A. S. (1996) TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NFkappaB. Science 274: 784-787.
110. Grimm, S., Bauer, M. K. A., Baeuerle, P. A., Schulze-Osthoff, K. (1996) Bcl-2 down-regulates the activity of transcription factor NFκB induced upon apoptosis. J. Cell Biol. 134: 13-23.
111. XL serve an anti-inflammatory function in endothelial cells through inhibition of NFκB. J. Clin. Invest. 103: 543-553.
112. Bauer, M. K. A., Vogt, M., Los, M., Siegel, J., Wesselborg, S., Schulze-Osthoff, K. (1998) Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273: 8048-8055.
113. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahoubi, A., Green, D. R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via activation of NF-kappa B and AP-1. Mol. Cell 1: 543-551.
114. Kothny-Wilkes, G., Kulms, D., Luger, T. A., Kubin, M., Schwarz, T. (1999) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J. Biol. Chem. 274, 28916-28921.
115. Hettmann, T., DiDonato, J., Karin, M., Leiden, J.M. (1999) An essential role for nuclear factor kB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189: 145-157.
116. Mayo, M. W., Madrid, L. V., Westerheide, S. D., Jones, D. R., Yuan, X. J., Baldwin, A. S. Jr., Whang, Y. E. (2002) PTEN blocks tumor necrosis factor-induced NFkappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J. Biol. Chem. 277: 11116-1125.
117. Wolff, B., Naumann, M. (1999) INK4 cell cycle inhibitors direct transcriptional inactivation of NFkappaB. Oncogene 18: 2663-2666.
118. Rocha, S., Campbell, K. J., Perkins, N. D. (2003) P53- and Mdm2-independent repression of NFkappa B transactivation by the ARF tumor suppressor. Mol. Cell 12: 51-25.
119. Campbell, K. J., Rocha, S., Perkins, N. D. (2004) Active repression of antiapoptotic gene expression by RelA(p65) NFkappaB. Mol. Cell 13: 853-865.
120. Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., Perkins, N. D. (2005) Regulation of NFkappaB and p53 through activation of ATR and Chk1 by the ARF tumor suppressor. EMBO J. 24: 1157-1169.
121. Cooper, S., Ranger-Moore, J., Bowden, T. G. (2005) Differential inhibition of UVB-induced AP-1 and NFkappaB transactivation by components of the jun bZIP domain. Mol. Carcinogen. 43: 108-116.
122. Wu, S., Tan, M., Hu, Y., Wang, J. L., Scheuner, D., Kaufmann, R. J. (2004) Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. J. Biol. Chem. 279: 34898-34902.
123. Thyss, R., Virolle, V., Imbert, V., Peyron, J. F., Aberdam, D., Virolle, T. (2005) NFκB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. EMBO J. 24: 128-137.
124. Li, Z., Niu, J., Uwagawa, T., Peng, B., Chiao, P. J. (2005) Function of polo-like kinase 3 in NFkappaB-mediated proapoptotic response. J. Biol. Chem. 280: 16843-16950.
125. Grilli, M., Memo, M. (1999) Possible role of NFκB and p53 in the glutamate-induced proapoptotic neuronal pathway. Cell Death Diff. 6: 22-27.
126. Din, F. V., Stark, L. A., Dunlop, M. G. (2005) Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Br. J. Cancer 92: 1137-1143.
127. Hardwick, J. C. H., van den Brink, G. R., Offerhaus G. J., van Deventer, S. J. H, Peppelenbosch, M. P. (2001) NFkappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonie adenomatous polyps. Oncogene 20: 819-827.
128. Grimm, T., Schneider, S., Naschberger, E., Huber, J., Guenzi, E., Kieser, A., Reitmeir, P., Schulz, T. F., Morris, C. A., Sturzl, M. (2005) EBV latent membrane protein-1 protects B cell from apoptosis by inhibition of Bax. Blood 105: 3263-3269.
129. Schauvliege, R., Vanrobaeys, J., Schotte, P., Beyaert, R. (2002) Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1. J. Biol. Chem. 277: 41624-41630.
130. Chan, H., Bartos, D. P., Owen-Schaub, L B. (1999) Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell. Biol. 19: 2098-2108.
131. Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A., Ju, S. T. (1998) Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161: 3469-3473.
132. De Smaele E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., Franzoso, G. (2001) Induction of gadd45beta by NF-kappaB downregulates proapoptotic JNK signalling. Nature 414: 308-313.
133. Duyao, M. P., Buckler, A. J., Sonenshein, G. E. (1990) Interaction of an NF-kappa B like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. U.S.A. 87:4727-4731.
134. La Roza, F. A., Pierce, J. W., Sonenshein, G. E. (1994) Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol. Cell. Biol. 14: 1039-1044.
135. Collart, M. A., Baeuerle, P., Vassalli, P. (1990) Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10: 1498-1506.
136. Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov S. A., Jongeneel, C. V. (1990) Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 171: 35-47.
137. Santee, S. M., Owen-Schaub, L. B. (1996) Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 271: 21151-21159.
138. Baetu, T. M., Kwon, H., Sharma, S., Grandvaux, N., Hiscott, J. (2001) Disruption of NF-kappaB in the regulation of TNF-ralated apoptosis inducing ligand expression. J. Immunol. 167: 3164-3173.
139. Matsuda, T., Almasan, A., Tomita, M., Uchihara J. N., Masuda, M., Ohshiro, K., Takasu, N., Yagita, H., Ohta, T., Mori, N. (2005) Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukaemia virus type 1-infected T-cell lines. J. Virol. 79: 1367-1378.
140. Catz, S. D., Johnson, J. L. (2001) Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20: 7342-7351.
141. Chen, F., Demers, L. M., Vallyathanm V., Lu, Y., Castranova, V., Shi, X. (1999) Involvement of 5-flanking kappaB-like sites within bcl-x gene in silica-induced Bcl-x expression. J. Biol. Chem. 274: 35592-35595.
142. Grummont, R. J., Rourke, I. J., Gerondakis, S. (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13: 400-411.
143. Kreuz, S., Siegmund, D., Scheurich, P., Wajant, H. (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signalling. Mol. Cell. Biol. 21:3964-3973.
144. Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J.A., Binder, B.R., Lipp, J. (1998) Nuclear factor (NF)-kappaB-regualted X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188: 211-216.
145. Hiscott, J., Marios, J., Garoufalis, J., D Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G., Fenton, M. (1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: Evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13: 6231-6240.
146. Schwenzer, R., Siemienski, K., Liptay, S., Schubert, G., Peters, N., Scheurch, P., Schmid, R. M., Wajant, H. (1999) The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF.-kappaB and c-Jun N-terminal kinase. J. Biol. Chem. 274, 19368-19374.
147. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., Baldwin, A. S. Jr. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
148. Hinata, K., Gervin A. M., Jennifer Zhang, Y., Khavari, P. A. (2003) Divergent gene regulation and groeth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 22: 1955-1964.
149. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., Baldwin, A. S. Jr. (1999) NF-kappaB controls cell growth and differentiation through transcriptional control of cyclin D1. Mol. Cell. Biol. 19: 5785-5799.
150. Huang, Y., Ohtani, K., Iwanga, R., Matsumura, Y., Nakamura, M. (2001) Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukaemia virus type I. Oncogene 20: 1094-1102.
151. Wang, Z., Sicinski, P., Weinberg, R. A., Zhang, Y., Ravid, K. (1996) Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. Genomics 35: 156-163.
152. Deregowski, V., Delhalle, S., Benoit, V., Bours, V., Merville, M.P. (2002) Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. Biochem. Pharmacol. 64: 873-881.